UK markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2180+0.0030 (+1.40%)
As of 01:32PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
30/04/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,444
7,446
5,201
1,311
1,069
Selling general and administrative
7,128
7,425
7,118
3,641
3,355
Total operating expenses
12,571
14,870
12,320
4,952
4,424
Operating income or loss
-12,571
-14,870
-12,320
-4,952
-4,424
Interest expense
22.021
7.701
46.524
158.803
-
Total other income/expenses net
-
-
4
62.418
-
Income before tax
-12,589
-14,878
-12,362
-5,047
-4,410
Income from continuing operations
-12,589
-14,878
-12,362
-5,047
-4,410
Net income
-12,589
-14,878
-12,362
-5,047
-4,410
Net income available to common shareholders
-12,589
-14,878
-12,362
-5,047
-4,410
Basic EPS
-
-0.15
-0.14
-0.06
-0.05
Diluted EPS
-
-0.15
-0.14
-0.06
-0.05
Basic average shares
-
97,519
89,095
84,930
89,763
Diluted average shares
-
97,519
89,095
84,930
89,763